Pena found that levels of behenoylcarnitine were positively associated with urinary albumin excretion and negatively associated with changes in estimated glomerular filtration rate (eGFR) [48], potentially reflecting reduced mitochondrial oxidative capacity observed in patients with type 2 diabetes mellitus [49]. This evidence concerns the gene ALB and diabetes mellitus.